We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Genmab AS | NASDAQ:GMAB | NASDAQ | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | |
|---|---|---|---|---|---|
| 0.00 | 0.00% | 28.47 | 28.10 | 29.01 |
| High Price | Low Price | Open Price | Traded | Last Trade |
|---|---|---|---|---|
| 0 | 01:00:00 |
| Date | Time | Source | Headline |
|---|---|---|---|
| 09/1/2024 | 12:45 | DJN | Pfizer, Genmab Get Speedy FDA Review of Tivdak Full Approval |
| 25/9/2023 | 13:50 | DJN | AbbVie, Genmab Get Conditional Europe OK of Tepkinly Lymphoma Drug |
| 28/6/2023 | 00:48 | DJN | AbbVie, Genmab Need Further Follow Up on Trial for Follicular Lymphoma.. |
1 Year Genmab AS Chart |
Intraday Genmab AS Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
